Analysis of genes governing the antibody response to type IIi pneumococcal polysaccharide (SSS-III)
Baker, P.J.; Amsbaugh, D.F.; Prescott, B.; Stashak, P.W.
Folia Biologica 22(6): 407-408
1976
ISSN/ISBN: 0015-5500 PMID: 12030 Document Number: 107705
Document emailed within 1 workday
Related Documents
Baker, P.J.; Stashak, P.W.; Amsbaugh, D.F.; Prescott, B. 1974: Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells Journal of Immunology 112(1): 404-409Markham, R.B.; Stashak, P.W.; Prescott, B.; Amsbaugh, D.F.; Baker, P.J. 1977: Effect of concanavalin a on lymphocyte interactions involved in the antibody response to type IIi pneumococcal polysaccharide I. Comparison of the suppression induced by con a and low dose paralysis Journal of Immunology 118(3): 952-956
Measel, J.W. 1982: The effect of the lymphatic pump on the immune response: I. Preliminary studies on the antibody response to pneumococcal polysaccharide assayed by bacterial agglutination and passive hemagglutination Journal of the American Osteopathic Association 82(1): 28-31
Sklenar, I.; Dürig, M.; Lydick, E.; Erb, P.; Harder, F. 1985: Antibody response to pneumococcal polysaccharide antigens following splenectomy and replantation of autologous splenic tissue Aktuelle Probleme in Chirurgie und Orthopadie 30: 107-112
Howard, J.G.; Christie, G.H.; Jacob, M.J.; Elson, J. 1970: Studies on immunological paralysis. 3. Recirculation and antibody-neutralizing activity of 14C-labelled type 3 pneumococcal polysaccharide in paralysed mice Clinical and Experimental Immunology 7(4): 583-596
Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800
Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800
Adderson, E.E.; Shackelford, P.G.; Quinn, A.; Carroll, W.L. 1991: Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide Journal of Immunology 147(5): 1667-1674
Cohn, D.A.; Schiffman, G. 1988: Minimal role for the spleen in antibody responses of C57BR/cdj mice to pneumococcal polysaccharide antigens Clinical and Experimental Immunology 72(1): 151-156
Braley-Mullen, H. 1975: Secondary IgG responses to type IIi pneumococcal polysaccharide. I. Kinetics and antigen requirements Journal of Immunology 115(5): 1194-1198
Braley-Mullen, H. 1976: Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation Journal of Immunology 116(4): 904-910
McCoy, K.L.; Baker, P.J.; Stashak, P.W.; Chused, T.M. 1985: Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type IIi pneumococcal polysaccharide Journal of Immunology 135(4): 2438-2442
Baker, P.J.; Amsbaugh, D.F.; Stashak, P.W.; Caldes, G.; Prescott, B. 1982: Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type IIi pneumococcal polysaccharide Journal of Immunology 128(3): 1059-1062
Parkkali, T.; Käyhty, H.; Ruutu, T.; Volin, L.; Eskola, J.; Ruutu, P. 1996: A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT Bone Marrow Transplantation 18(5): 961-967
Nurmi, T.; Leinonen, M.; Häivä, V.M.; Tiilikainen, A.; Kouvalainen, K. 1982: Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome) Clinical and Experimental Immunology 48(2): 485-490
Epstein, M.M.; Gruskay, F. 1995: Selective deficiency in pneumococcal antibody response in children with recurrent infections Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 75(2): 125-131
Braley-Mullen, H. 1980: Direct demonstration of specific suppressor T cells in the mice tolerant to type IIi pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells Journal of Immunology 125(4): 1849-1854
Lucas, A.H.; Moulton, K.D.; Reason, D.C. 1998: Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide Journal of Immunology 161(7): 3776-3780
Iribe, H.; Kabashima, H.; Koga, T. 1989: Antibody response against a possible arthritogenic epitope on human type Ii collagen induced by anti-idiotypic antibody Journal of Immunology 142(5): 1487-1494
Schneerson, R.; Robbins, J.B.; Barrera, O.; Sutton, A.; Habig, W.B.; Hardegree, M.C.; Chaimovich, J. 1980: Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines Progress in Clinical and Biological Research 47: 77-94